Published in BMC Gastroenterol on November 18, 2014
Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med (2012) 16.55
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin (2008) 12.90
Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev (2010) 12.60
Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med (2010) 11.76
Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol (2002) 6.63
Sex-specific prevalence of adenomas, advanced adenomas, and colorectal cancer in individuals undergoing screening colonoscopy. JAMA (2011) 4.21
Quality indicators for colonoscopy. Gastrointest Endosc (2006) 3.83
Prevalence of missed adenomas in patients with inadequate bowel preparation on screening colonoscopy. Gastrointest Endosc (2012) 3.69
Predictors of inadequate bowel preparation for colonoscopy. Am J Gastroenterol (2001) 3.33
Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy. Gastroenterology (2013) 3.25
The impact of suboptimal bowel preparation on adenoma miss rates and the factors associated with early repeat colonoscopy. Gastrointest Endosc (2011) 2.73
Polypectomy rate: a surrogate for adenoma detection rate varies by colon segment, gender, and endoscopist. Clin Gastroenterol Hepatol (2013) 2.22
Polyp and adenoma detection rates in the proximal and distal colon. Am J Gastroenterol (2013) 1.98
Prevalence of adenomas and colorectal cancer in average risk individuals: a systematic review and meta-analysis. Clin Gastroenterol Hepatol (2009) 1.88
Incidence and age distribution of colorectal cancer in Iran: results of a population-based cancer registry. Cancer Lett (2005) 1.53
Gender as a risk factor for advanced neoplasia and colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol (2009) 1.47
Epidemiology and molecular genetics of colorectal cancer in iran: a review. Arch Iran Med (2009) 1.35
Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention. World J Gastroenterol (2014) 1.35
The impact of patient education on the quality of inpatient bowel preparation for colonoscopy. Can J Gastroenterol (2010) 1.06
Assessment of adenoma detection rate benchmarks in women versus men. Gastrointest Endosc (2013) 1.05
The quality of colonoscopy services--responsibilities of referring clinicians: a consensus statement of the Quality Assurance Task Group, National Colorectal Cancer Roundtable. J Gen Intern Med (2010) 1.02
Knowledge and practice of iranians toward colorectal cancer, and barriers to screening. Int J Prev Med (2012) 1.01
Quality indicators for colonoscopy procedures: a prospective multicentre method for endoscopy units. PLoS One (2012) 0.97
Measurement of adenoma detection and discrimination during colonoscopy in routine practice: an exploratory study. Gastrointest Endosc (2011) 0.96
Delivering colonoscopy screening for low-income populations in Suffolk County: strategies, outcomes, and benchmarks. Cancer (2013) 0.89
Effect of physician-delivered patient education on the quality of bowel preparation for screening colonoscopy. Gastroenterol Res Pract (2013) 0.87
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ (2009) 5.79
Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90
Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care (2007) 3.57
The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med (2009) 2.67
Screening of the adult population in Iran for coeliac disease: comparison of the tissue-transglutaminase antibody and anti-endomysial antibody tests. Eur J Gastroenterol Hepatol (2006) 2.63
Effectiveness of diabetes and hypertension management by rural primary health-care workers (Behvarz workers) in Iran: a nationally representative observational study. Lancet (2011) 2.61
Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int J Cancer (2003) 2.53
Obesity and associated lifestyle behaviours in Iran: findings from the First National Non-communicable Disease Risk Factor Surveillance Survey. Public Health Nutr (2007) 2.44
Seroprevalence of hepatitis C virus: the first population-based study from Iran. Int J Infect Dis (2010) 2.32
Association of physical activity and dietary behaviours in relation to the body mass index in a national sample of Iranian children and adolescents: CASPIAN Study. Bull World Health Organ (2007) 2.30
Smoking behavior and its influencing factors in a national-representative sample of Iranian adolescents: CASPIAN study. Prev Med (2006) 2.13
Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med (2007) 2.12
Cohort Profile: The Golestan Cohort Study--a prospective study of oesophageal cancer in northern Iran. Int J Epidemiol (2009) 2.10
Opium use and risk of mortality from digestive diseases: a prospective cohort study. Am J Gastroenterol (2013) 2.07
Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50,000 adults in Iran. BMJ (2012) 2.07
The gastro-esophageal malignancies in Northern Iran research project: impact on the health research and health care systems in Iran. Arch Iran Med (2013) 2.01
First nationwide survey of prevalence of overweight, underweight, and abdominal obesity in Iranian adults. Obesity (Silver Spring) (2007) 2.01
Generation of liver disease-specific induced pluripotent stem cells along with efficient differentiation to functional hepatocyte-like cells. Stem Cell Rev (2010) 1.98
Applying a natural language processing tool to electronic health records to assess performance on colonoscopy quality measures. Gastrointest Endosc (2012) 1.96
Esophageal cancer in Northeastern Iran: a review. Arch Iran Med (2007) 1.95
Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran. Cancer Epidemiol Biomarkers Prev (2004) 1.95
Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population. J Hypertens (2013) 1.86
Cancer incidence in Golestan Province: report of an ongoing population-based cancer registry in Iran between 2004 and 2008. Arch Iran Med (2012) 1.84
Socio-economic status and oesophageal cancer: results from a population-based case-control study in a high-risk area. Int J Epidemiol (2009) 1.77
Obesity and hypertension in an Iranian cohort study; Iranian women experience higher rates of obesity and hypertension than American women. BMC Public Health (2006) 1.75
Comparison of existing clinical scoring systems to predict persistent organ failure in patients with acute pancreatitis. Gastroenterology (2012) 1.71
Polycyclic aromatic hydrocarbon exposure in oesophageal tissue and risk of oesophageal squamous cell carcinoma in north-eastern Iran. Gut (2010) 1.71
High prevalence of coeliac disease in apparently healthy Iranian blood donors. Eur J Gastroenterol Hepatol (2003) 1.69
Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study. Am J Clin Nutr (2014) 1.66
Declining incidence of esophageal cancer in the Turkmen Plain, eastern part of the Caspian Littoral of Iran: a retrospective cancer surveillance. Cancer Detect Prev (2006) 1.65
Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis. Liver Int (2013) 1.64
Reversibility of cirrhosis in autoimmune hepatitis. Am J Med (2004) 1.64
Healthy ranges of serum alanine aminotransferase levels in Iranian blood donors. World J Gastroenterol (2003) 1.63
Cancer incidence in Tehran metropolis: the first report from the Tehran Population-based Cancer Registry, 1998-2001. Arch Iran Med (2009) 1.59
Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes. World J Gastroenterol (2008) 1.59
Survival rate of gastric and esophageal cancers in Ardabil province, North-West of Iran. Arch Iran Med (2007) 1.58
High exposure to polycyclic aromatic hydrocarbons may contribute to high risk of esophageal cancer in northeastern Iran. Anticancer Res (2005) 1.57
Prevalence of celiac disease among patients with Behcet's disease in Iran. Dig Dis Sci (2008) 1.54
Incidence and age distribution of colorectal cancer in Iran: results of a population-based cancer registry. Cancer Lett (2005) 1.53
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Coeliac disease in autoimmune liver disease: a cross-sectional study and a systematic review. Dig Liver Dis (2010) 1.49
Brain-derived neurotrophic factor predicts physical health in untreated patients with hepatitis C. Biol Psychiatry (2011) 1.49
Tooth loss and lack of regular oral hygiene are associated with higher risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2008) 1.47
Probucol in the treatment of nonalcoholic steatohepatitis: an open-labeled study. J Clin Gastroenterol (2003) 1.47
Verbal autopsy: reliability and validity estimates for causes of death in the Golestan Cohort Study in Iran. PLoS One (2010) 1.47
Ecologic study of serum selenium and upper gastrointestinal cancers in Iran. World J Gastroenterol (2004) 1.47
Surface area: a better predictor of disease severity than the height and volume of the barium column in patients with primary achalasia. Eur J Gastroenterol Hepatol (2006) 1.45
Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease. Am J Gastroenterol (2006) 1.41
Topography of gastritis and its severity in 864 first degree relatives of gastric cancer patients. Arch Iran Med (2010) 1.41
Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol (2007) 1.39
Molecular epidemiology of hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B region. J Med Virol (2004) 1.38
Prevalence, awareness, treatment, and risk factors associated with hypertension in the Iranian population: the national survey of risk factors for noncommunicable diseases of Iran. Am J Hypertens (2008) 1.36
A survey of the current status of web-based databases indexing Iranian journals. Arch Iran Med (2009) 1.35
Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study. Arch Iran Med (2010) 1.35
Epidemiology and molecular genetics of colorectal cancer in iran: a review. Arch Iran Med (2009) 1.35
Long-term protection provided by hepatitis B vaccine and need for booster dose: a meta-analysis. Vaccine (2009) 1.34
Appropriate waist circumference cut-off points among Iranian adults: the first report of the Iranian National Committee of Obesity. Arch Iran Med (2010) 1.33
Nationwide survey of prevalence and risk factors of prehypertension and hypertension in Iranian adults. J Hypertens (2008) 1.32
Paediatric metabolic syndrome and associated anthropometric indices: the CASPIAN Study. Acta Paediatr (2006) 1.32
Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer. World J Gastroenterol (2006) 1.30
Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors. J Gastroenterol Hepatol (2005) 1.30
Epidemiologic characteristics of 500 patients with inflammatory bowel disease in Iran studied from 2004 through 2007. Arch Iran Med (2009) 1.28
Epidemiology of gastroesophageal reflux symptoms in Tehran, Iran: a population-based telephone survey. Arch Iran Med (2007) 1.27
Oesophageal cancer in Golestan Province, a high-incidence area in northern Iran - a review. Eur J Cancer (2009) 1.27
The upper normal limit of serum alanine aminotransferase in Golestan Province, northeast Iran. Arch Iran Med (2008) 1.25
Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of Obesity. Arch Iran Med (2010) 1.25
Association of physical activity and the metabolic syndrome in children and adolescents: CASPIAN Study. Horm Res (2006) 1.24
In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis. Nucl Med Biol (2011) 1.22
The role of diet and other environmental factors in the causation of gastric cancer in Iran--a population based study. Int J Cancer (2009) 1.21
Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B. BMC Gastroenterol (2005) 1.21
Human papillomavirus in squamous cell carcinoma of esophagus in a high-risk population. World J Gastroenterol (2005) 1.21
Comparison of breast cancer survival in two populations: Ardabil, Iran and British Columbia, Canada. BMC Cancer (2009) 1.20